Pharmacolog appoints Markku Matkoski as Development Manager. Markku has extensive experience in product development and project management and will take up his position on 17/9 2020. Markku most recently came from Elekta AB, where he had the role of Manager Adaptive Dose Software.
As development manager, Markku will be responsible for the Company’s development projects together with a team of qualified engineers and programmers. Markku has studied computer science and numerical analysis at Uppsala University and previous experience includes a number of positions at Helax AB, Nucletron AB and Elekta AB, including as Manager Treatment Planning Software. Markku replaces the current development manager Lars Gusch.
CEO Mats Högberg comments. “We are very pleased that Markku has chosen to accept the role of Development Manager. As we are facing an exciting phase with a number of exciting collaborative projects, we need an experienced development manager. I would also like to take this opportunity to thank Lars for an exceptionally good collaboration. Lars has been instrumental in streamlining and documenting our internal processes and leading the project with our ISO certification. I wish Lars good luck with his continued career.”
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.